Loading insider details...
Latest Form 4 (Nov 13, 2026): Exercise/Conversion of 22,500 DCTH shares, $176.6K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Nov 13, 2026 | DELCATH SYSTEMS, INC. (DCTH) | Exercise/Conversion | 22,500 | $176.6K |
| Jun 29, 2026 | Aligos Therapeutics, Inc. (ALGS) | Grant/Award | 5,860 | n/a |
| May 14, 2026 | DELCATH SYSTEMS, INC. (DCTH) | Grant/Award | 22,500 | n/a |
| Jun 26, 2025 | Aligos Therapeutics, Inc. (ALGS) | Grant/Award | 5,860 | n/a |
| Jun 10, 2025 | ACHIEVE LIFE SCIENCES, INC. (ACHV) | Grant/Award | 31,500 | n/a |
| May 19, 2025 | DELCATH SYSTEMS, INC. (DCTH) | Grant/Award | 22,500 | n/a |
| Jun 28, 2024 | Aligos Therapeutics, Inc. (ALGS) | Grant/Award | 60,000 | n/a |
| May 28, 2024 | DELCATH SYSTEMS, INC. (DCTH) | Grant/Award | 22,500 | n/a |
| Feb 28, 2024 | Aligos Therapeutics, Inc. (ALGS) | Disposition to Issuer | 30,000 | n/a |
| Jan 29, 2024 | ACHIEVE LIFE SCIENCES, INC. (ACHV) | Grant/Award | 31,500 | n/a |